Contaminated Eyedrops Alert Worldwide | Deaths and vision loss recorded. Beware of the brands

Contaminated Eyedrops Alert Worldwide | Deaths and vision loss recorded. Beware of the brands

Issued on the 23rd March 2023 about a Contaminated Eyedrops alert worldwide, the Foods and Drugs Authority has released an official statement below.

 

Highlights

1. EZRICARE ARTIFICIAL TEARS and DELSAM PHARMA’S ARTIFICIAL TEARS owned by Global Pharma are contaminated

2. Global Pharma has since issued a voluntary recall of the product.

3. The US Center for Disease Control and Prevention has classified the incident as an outbreak.

4. The eyedrops were found to contain the drug-resistant bacteria pseudomonas aeruginosa.

5. The eyedrops are suspected to have led to three deaths and vision loss in eight (8) patients.

6. According to the Food and Drugs Authority, the products have not been registered by it and therefore, the products are not expected to be on the Ghanaian market. However, the FDA advices the public to be vigilant. Also, anyone who may have had access to the drugs through any other means is advised to stop using them. Below is the FDA’s statement

The Foods and Drugs Authority (FDA) is alerting the public about a recent major incidence of contamination of two Eyedrops, EZRICARE ARTIFICIAL TEARS and DELSAM PHARMA’S ARTIFICIAL TEARS, owned by Global Pharma. Global Pharma has since issued a voluntary recall of the products.

The US Center for Disease Control and Prevention (USCDC) has classified the incident as an outbreak. According to the USCDC, the Eyedrops were found to contain the drug-resistant bacteria pseudomonas aeruginosa and it is suspected to have led to three deaths and vision loss in eight patients.

The products are not registered with the Ghana FDA. Therefore, they should not be commercially available on the Ghanaian market. However, the FDA advises the public who may be in possession of these drugs through other means to immediately stop using these recalled drugs, Ezricare Artificial Tears and Delsam Pharma’s Artificial Tears, and submit them to any of the FDA offices nationwide.

Anyone who has used these recalled products and is experiencing any symptoms should contact a healthcare professional immediately. Reported symptoms include yellow, green, or clear discharge from the eye, eye pain or discomfort, redness, feeling something in the eye, increased sensitivity to light and blurred vision.

See also: FDA Announced Suspected falsified Antimalarial Drug on Ghana Market |Find out the Drug Here

The FDA assures the public that it is taking all necessary measures to ensure that only safe and effective medical products are available in Ghana.

The public is encouraged to report any adverse effects or quality problems related to the use of medical products to the FDA through its MEDSAFETY APP.

Source: fdaghana.gov.gh

To be informed about relevant information, join us on WhatsApp or Telegram or Facebook

About Author

Join our social media platforms

Join Educative News Room for regular updates about related topics

Join Telegram or Join WhatsApp or Join Facebook or Join Twitter(X)